Last Updated: September 28, 2026

ANEXSIA 7.5 Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Anexsia 7.5, and what generic alternatives are available?

Anexsia 7.5 is a drug marketed by Specgx Llc and Mallinckrodt and is included in two NDAs.

The generic ingredient in ANEXSIA 7.5 is acetaminophen; hydrocodone bitartrate. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ANEXSIA 7.5?
What are the global sales for ANEXSIA 7.5?
What is Average Wholesale Price for ANEXSIA 7.5?

Summary for ANEXSIA 7.5

US Patents:	0
Applicants:	2
NDAs:	2

US Patents and Regulatory Information for ANEXSIA 7.5

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Specgx Llc	ANEXSIA 7.5/325	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	040405-001	Sep 8, 2000	AA	RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Mallinckrodt	ANEXSIA 7.5/650	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	089725-001	Sep 30, 1987		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.